HeartSciences (HSCS) Stock Forecast: StockMap's 2-Week Call
HSCS stock forecast: StockMap's model leans Underperform on HeartSciences for the two weeks after the Nov 13 close, toward HSCS trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 6 two-week windows on HSCS since Aug 21; by chance, a call on the same dates was right 62% of the time.
HeartSciences last closed at $2.12, -6.19% on the session.
Against the IVW growth benchmark the position is -5.28% over the forecast window.
HeartSciences' market cap is $10.53M as of November 13, 2026.
Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -45 (too close to call).
Where HSCS sits: sized by market cap, coloured by the day's move.
The read is built from 11 underlying insights — 0 bullish and 11 bearish.
Agreement across those insights is 100%.
39 daily calls for HSCS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks HeartSciences in the 1st percentile on return on equity, where 100 is best.
HeartSciences is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks HeartSciences as the 130th largest of the 142 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 74 Neutral, 52 Moderate Underperform, 13 Strong Underperform and 3 Moderate Outperform.
On that composite HeartSciences ranks 123rd of 142 in the group, against a group median of -0.15.